PDI inks one-year sales agreementContract sales firm PDI has inked a one-year sales agreement for a cardiology drug with an unnamed “top-10 pharmaceutical company.”
The initiative, expected to bring in $13 million in revenue, will target primary care physicians and cardiologists and was scheduled to begin April 2.
The announcement is viewed as a much-needed boost for PDI, which announced a decision by a “large pharma company” client not to renew a $35 million contract sales engagement with the firm. PDI previously expected that one-year deal to be extended through the end of 2007.
PDI has endured four major contract losses during the past year.